Allergy Therapeutics (UK) Limited
- Address
- Dominion Way
Sponsor Overview
Specializations
Allergic Rhinitis and Rhinoconjunctivitis
Clinical research is centred on seasonal allergic rhinitis and rhinoconjunctivitis, with attention to symptoms linked to birch pollen and grass pollen exposure.
- Birch pollen-induced allergy
- Grass pollen-induced allergy
- Seasonal nasal and ocular symptoms
The sponsor’s clinical portfolio reflects a focused interest in respiratory allergy conditions affecting the upper airways and eyes.
Paediatric Allergy Care
Research includes paediatric subjects with grass pollen-induced seasonal allergic rhinitis and rhinoconjunctivitis, highlighting interest in allergy management across younger age groups.
- Paediatric seasonal allergy
- Grass pollen sensitivity
- Childhood respiratory allergy
This area supports investigation of allergic disease patterns and treatment needs in children and adolescents.
Pollen-Driven Immunotherapy
The sponsor’s studies are directed toward pollen allergy interventions for birch and grass exposure, with a strong therapeutic interest in seasonal allergen-related disease.
- Birch allergen targets
- Grass allergen targets
- Seasonal allergen treatment
Research activity is distributed across multiple countries and collaborating sites, supporting work in geographically diverse allergy populations.
Upper Airway Allergy Symptoms
Clinical interest extends to the symptom burden of upper airway allergic disease, including both nasal and eye manifestations associated with seasonal pollen exposure.
- Nasal symptoms
- Ocular symptoms
- Seasonal symptom control
These studies align with therapeutic areas concerned with the management of recurrent seasonal allergy presentations.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety Evaluation of PQ Birch in Patients with Birch Pollen-Induced Seasonal Allergic Rhinitis and Rhinoconjunctivitis |  Austria Germany Poland | Not Yet Recruiting |
| Efficacy and Safety Evaluation of PQ Grass 27600 SU in Pediatric Patients with Grass Pollen-Induced Seasonal Allergic Rhinitis/Rhinoconjunctivitis |  Bulgaria Czechia Germany Lithuania Poland Romania Slovakia | Recruiting |
Data & Insights
This sponsor works with 11 molecules, of which 4 are not being studied by other sponsors.
This sponsor has worked with 106 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases2 trials322 other sponsors
Partnered Research Centres
106 centres- Address
- Reumannplatz 17, Favoriten, 1100 Vienna
- Address
- Ul. Polskiego Czerwonego Krzyza 26, 33-100 Tarnow
- Address
- Pck 26 Street, 33-100 Tarnow
- Address
- Hradska Cesta 2, 060 01 Kežmarok
- Address
- Korunni 595/76, Marianske Hory, 709 00 Ostrava
- Address
- Al. Gen. Jozefa Hallera 95, 53-201 Wroclaw
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Allergy Therapeutics (UK) Limited.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.